Liberation Way, LLC

Liberation Way, LLC is a US-based company specializing in comprehensive inpatient drug and alcohol rehabilitation services, offering tailored treatment programs to support individuals in overcoming addiction. Founded in 2014, Liberation Way provides inpatient rehabilitation services focused on substance use disorders. The company has undergone strategic pivots to enhance its offerings. Currently headquartered in the US, the firm does not operate under any parent company nor does it have subsidiaries.

The CEO, Dallas Fetterman, has been pivotal in the company's direction. In May 2018, Liberation Way received investment from Fulcrum Equity Partners and Vocap Investment Partners, acquiring a majority stake in the company. Liberation Way specializes in comprehensive inpatient drug and alcohol rehabilitation services, offering a range of treatment programs designed to address various substance use disorders. Their core product offerings include medically supervised detoxification, individual and group therapy sessions, and holistic treatment options such as yoga and mindfulness training.

These services are structured to provide clients with the necessary support to overcome addiction and achieve long-term recovery. The company primarily serves individuals seeking to reclaim their lives from addiction, with a client base that encompasses various demographics, including young adults, professionals, and families affected by substance abuse. Liberation Way operates in multiple geographical markets across the United States, focusing on areas with a high demand for addiction treatment services. Liberation Way generates revenue through direct-to-consumer transactions, where clients pay for inpatient rehabilitation services.

The business model typically involves upfront payments for treatment programs, which may include varying lengths of stay and specific care packages tailored to individual needs. Although precise pricing details are not disclosed, clients can expect structured payment plans based on the types of services chosen, such as detoxification or extended rehabilitation. The company may also engage in partnerships with healthcare providers and insurance companies to facilitate access to its treatment programs, thereby increasing its client base and enhancing service delivery. This transactional framework highlights the firm’s commitment to providing accessible and effective rehabilitation solutions for individuals struggling with addiction.

Liberation Way's growth strategy includes plans to design and launch new treatment programs, although specific release dates are not disclosed. The company aims to expand its reach into new markets, focusing on regions with a high demand for addiction services across the United States. Recent funding from the majority acquisition in May 2018 will be utilized to support these initiatives, although detailed allocation plans are not specified.